Glen Eagle Advisors, LLC Clear Point Neuro, Inc. Transaction History
Glen Eagle Advisors, LLC
- $604 Billion
- Q1 2025
A detailed history of Glen Eagle Advisors, LLC transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 50 shares of CLPT stock, worth $541. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 50
-0.0%
Holding current value
$541
Previous $769,000
22.63%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CLPT
# of Institutions
108Shares Held
8.67MCall Options Held
243KPut Options Held
30.2K-
Vanguard Group Inc Valley Forge, PA1.48MShares$16 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny741KShares$8.02 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA625KShares$6.76 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA482KShares$5.22 Million0.0% of portfolio
-
Black Rock Inc. New York, NY366KShares$3.96 Million0.0% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $265M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...